Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT02784158 |
| Title | An Expanded Access Study of Brigatinib for Patients With ALK-positive Advanced Non-Small Cell Lung Cancer |
| Recruitment | No longer available |
| Gender | both |
| Phase | Phase I |
| Variant Requirements | Yes |
| Sponsors | Ariad Pharmaceuticals |
| Indications | |
| Therapies | |
| Age Groups: | senior | adult |
| Covered Countries | USA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| UC San Diego Moores Cancer Center (Site 099) | La Jolla | California | 92093-0698 | United States | Details | |
| UCI Medical Center-Chao Family Comprehensive (Site 210) | Orange | California | 92868-3201 | United States | Details | |
| Karmanos Cancer Institute (Site 070) | Detroit | Michigan | 48201 | United States | Details |